In patients with remote PCI and a high risk of recurrent ischaemic events, clopidogrel monotherapy showed a directionally consistent reduction in the composite endpoint of all-cause death, myocardial infarction, or stroke compared with aspirin in both females and males, supporting the consistency of the treatment effec...
Woo-Duk Kwon, Ki H. Choi, Yonghwan Park et al.· EuroIntervention· 0 citations
Abstract Background The clinical effects of dual antiplatelet therapy de-escalation after acute myocardial infarction may differ by age. We evaluated whether the efficacy and safety of de-escalation from ticagrelor to clopidogrel differed by age in stabilized patients after percutaneous coronary intervention (PCI). Pat...
Seonghyeon Bu, Jaehyuk Jang, Sang Hyun Kim et al.· Annals medicus· 0 citations
Familial hypercholesterolemia (FH) is a well-established risk factor for coronary artery disease (CAD). However, its significance among patients with acute myocardial infarction (AMI) remains incompletely characterized, particularly in East Asia.
We analyzed data from a multicenter, retrospective AMI regis...
Kyung An Kim, J. Byeon, Sang Hyun Kim et al.· BMC Cardiovascular Disorders· 0 citations
BACKGROUND AND OBJECTIVES
This study aimed to evaluate the prognostic impact of high residual inflammatory risk (RIR) in patients with acute myocardial infarction (AMI) who underwent percutaneous coronary intervention (PCI) and achieved optimal low-density lipoprotein cholesterol (LDL-C) control.
METHODS
A retrospect...
Sangho Hyun, Kyung An Kim, Sang Hyun Kim et al.· Korean Circulation Journal· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.